This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) slid 1.31% to $312.17 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.13% to 7,609.78 and the Dow Jones Industrial Average rising 0.45% to 51,307.79.
This was the stock's second consecutive day of losses.
West Pharmaceutical Services Inc. closed 5.65% short of its 52-week high of $330.88, which the company reached on May 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 0.92% to $86.97, Becton Dickinson &amp; Co. (BDX) fell 0.62% to $144.43, and Baxter International Inc. (BAX) rose 1.52% to $18.68.
Trading volume (700,420) remained 181,102 below its 50-day average volume of 881,522.
Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-02-26 1704ET

West Pharmaceutical Services (WST) shares fell 1.31% to $312.17 on Tuesday, underperforming the broader market and key competitors like Abbott Laboratories and Baxter International. This marks the second consecutive day of losses for WST, which remains 5.65% below its 52-week high. Trading volume was notably lower than the 50-day average.

MarketWatch Automated

West Pharmaceutical

S&P 500

Dow Jones Industrial Average

West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors